• 1. Triethylborane-mediated atom-transfer cyclisation of 2-iodo-N-(prop-2-enyl)acetamides and related compounds
  Masazumi Ikeda,Hirotaka Teranishi,Kohei Nozaki,Hiroyuki Ishibashi J. Chem. Soc. Perkin Trans. 1 1998 1691
• 2. Efficient oxidative radical spirolactamization
  Tannya R. Ibarra-Rivera,Rocio Gámez-Monta?o,Luis D. Miranda Chem. Commun. 2007 3485
• 3. Asymmetric synthesis with ynamides: unique reaction control, chemical diversity and applications
  Ciarán C. Lynch,Archita Sripada,Christian Wolf Chem. Soc. Rev. 2020 49 8543
• 4. Deep-bed filters as post-treatment for ozonation in tertiary municipal wastewater treatment: impact of design and operation on treatment goals
  Daniel Sauter,Agata D?browska,Robert Bloch,Michael Stapf,Ulf Miehe,Alexander Sperlich,Regina Gnirss,Thomas Wintgens Environ. Sci.: Water Res. Technol. 2021 7 197
• 5. Polymorphic gabapentin: thermal behaviour, reactivity and interconversion of forms in solution and solid-state
  Dario Braga,Fabrizia Grepioni,Lucia Maini,Katia Rubini,Marco Polito,Roberto Brescello,Livius Cotarca,M. Teresa Duarte,Vania André,M. Fátima M. Piedade New J. Chem. 2008 32 1788

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Azaspirodecane derivatives Azaspirodecane derivatives
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Azaspirodecane derivatives

Chemical Profile of 2-Azaspiro[4.5]decan-3-one (CAS No: 64744-50-9)

2-Azaspiro[4.5]decan-3-one, identified by its Chemical Abstracts Service (CAS) number 64744-50-9, is a heterocyclic compound that has garnered significant attention in the field of medicinal chemistry due to its unique structural and pharmacological properties. This spirocyclic ketone features a nitrogen atom integrated into a spirocyclic framework, combining a cyclopentane ring with a cyclohexane ring linked by a single carbon atom. The presence of the carbonyl group at the third position enhances its reactivity, making it a versatile scaffold for synthetic modifications and drug development.

The compound’s structure imparts distinct physicochemical properties, including moderate lipophilicity and adequate solubility in common organic solvents, which are critical factors in drug formulation and bioavailability. Its spirocyclic nature contributes to steric hindrance, potentially influencing binding affinity to biological targets. These characteristics have positioned 2-Azaspiro[4.5]decan-3-one as a promising intermediate in the synthesis of biologically active molecules.

In recent years, the pharmaceutical industry has shown increasing interest in spirocyclic compounds due to their potential to exhibit enhanced metabolic stability and reduced toxicity compared to acyclic analogs. The nitrogen atom in 2-Azaspiro[4.5]decan-3-one further expands its utility, as it can serve as a site for further functionalization, enabling the attachment of pharmacophoric groups through various chemical reactions such as nucleophilic substitution or condensation reactions.

One of the most compelling aspects of 2-Azaspiro[4.5]decan-3-one is its role as a precursor in the synthesis of potential therapeutic agents. Researchers have leveraged its framework to develop molecules with activities ranging from anti-inflammatory to anticancer effects. For instance, derivatives of this compound have been explored for their ability to modulate enzyme activity by acting as competitive inhibitors or modulators of protein-protein interactions. The spirocyclic core provides a rigid scaffold that can mimic natural product structures, which are often recognized as biologically potent.

The synthesis of 2-Azaspiro[4.5]decan-3-one typically involves multi-step organic transformations, starting from readily available precursors such as cyclopentanones and cyclohexanones. Key steps often include cyclization reactions followed by functional group interconversions to introduce the nitrogen atom and the carbonyl group at the appropriate positions. Advances in synthetic methodologies have enabled more efficient and scalable production processes, making this compound more accessible for research and development purposes.

Recent studies have highlighted the compound’s utility in medicinal chemistry by demonstrating its ability to serve as a building block for novel drug candidates. For example, modifications at the nitrogen position have led to derivatives with improved binding affinities for specific biological targets, such as kinases or transcription factors implicated in various diseases. Additionally, computational studies have been employed to predict the binding modes of these derivatives, providing insights into their mechanism of action and optimizing their pharmacological profiles.

The versatility of 2-Azaspiro[4.5]decan-3-one extends beyond its role as an intermediate; it also serves as an inspiration for designing new heterocyclic systems with tailored properties. By incorporating additional functional groups or altering the spirocyclic core, chemists can generate libraries of compounds with diverse biological activities. This approach aligns with the growing trend toward structure-based drug design, where computational tools are used to guide the synthesis of molecules with enhanced efficacy and selectivity.

The future prospects for 2-Azaspiro[4.5]decan-3-one are promising, with ongoing research focusing on expanding its synthetic applications and exploring new therapeutic avenues. Collaborative efforts between synthetic chemists and biochemists are essential to fully harness its potential in drug discovery programs. As our understanding of molecular recognition continues to evolve, compounds like 2-Azaspiro[4.5]decan-3-one will undoubtedly play a crucial role in developing next-generation therapeutics.

In conclusion, 2-Azaspiro[4.5]decan-3-one (CAS No: 64744-50-9) represents a significant asset in medicinal chemistry due to its unique structural features and synthetic flexibility. Its spirocyclic framework combined with functionalizable sites offers unparalleled opportunities for designing novel bioactive molecules. As research progresses, this compound is expected to contribute significantly to advancements in drug development across multiple therapeutic domains.

• 316790-93-9(4-methyl-2-Azaspiro[4.5]decan-1-one)
• 880271-29-4(8-amino-2-Azaspiro[4.5]decan-3-one)
• 196618-65-2(Spiro[bicyclo[3.3.1]nonane-9,3'-pyrrolidin]-5'-one)
• 1005-85-2(2-Azaspiro[4.5]decan-1-one)
• 608532-84-9(2-Azaspiro[4.5]decan-3-one, 4,4-dimethyl-)
• 335671-45-9(Spiro[2H-indene-2,3'-pyrrolidin]-5'-one,octahydro-, (3aR,7aS)-rel-)
• 646055-89-2(Spiro[bicyclo[2.2.2]octane-2,3'-pyrrolidin]-2'-one)
• 335458-42-9(Spiro[2H-indene-2,3-pyrrolidin]-5-one, octahydro-, (3aR,6aR)-rel- (9CI))
• 196608-67-0(2-Azaspiro[4.5]decan-3-one, 7-methyl-, (5R,7R)-)
• 473829-20-8